UNSPSC 85512731: Supplement right renal artery with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right renal artery with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04U93KZ

UNSPSC 85512731 Supplement right renal artery with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity for state and local procurement. The code nominally describes a specific surgical procedure — supplementation of the right renal artery using a non-autologous tissue substitute via percutaneous access — a clinical intervention typically associated with hospital-based vascular surgery and performed within an acute care or specialty center setting. The recent state and local opportunities posted under this code, however, span independent medical evaluations for public safety pension systems, occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-out programs, and emergency medical services for detained youth. None of these solicitations align with the code's stated scope of vascular surgical procedure augmentation; instead, they reflect administrative health services procurement, staffing vehicles, and benefits management.

The mismatch between the code's nominal scope and the actual work being solicited suggests the code has been misapplied in the source data. State and local buyers do not appear to be sourcing renal artery supplementation procedures themselves; instead, the opportunities reflect health system and municipal procurement of clinical administration, staffing, and benefits intermediation. Without evidence of legitimate procurement activity matching the code's stated surgical procedure, this code does not present a meaningful market signal for vendors seeking state and local contract opportunity in vascular surgical intervention or related implant supply.